Pill Penalty: Pharma’s Challenges in a Shifting Landscape
JPM 2025 Highlights The annual J.P. Morgan Healthcare Conference (JPM) in 2025 showcased the dynamic evolution of the pharmaceutical industry, continuing its tradition of major announcements and thought-provoking discussions. This year, mergers and acquisitions (M&A) took center stage, with total deals exceeding $18 billion. Leading the announcements was Johnson & Johnson’s $14.6 billion acquisition of Intra-Cellular Therapies, followed by GSK’s ...
